Sanofi to work with Curie on ovarian cancer targets

06/20/2013 | GenomeWeb Daily News (free registration)

Sanofi and the Curie Institute have agreed to cooperate in the search for new therapeutic targets for ovarian cancer using next-generation sequencing, reverse-phase protein analysis and patient-derived xenografts. The three-year collaboration seeks "to gain a better understanding of the molecular alterations that characterize many types of ovarian cancer, thereby enabling effective new drugs to be designed," the partners said.

View Full Article in:

GenomeWeb Daily News (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX